Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
Akira Wada,1,2 Yasuto Kunii,1 Jyunya Matsumoto,1 Mizuki Hino,1 Atsuko Nagaoka,1 Shin-ichi Niwa,3 Hirooki Yabe1 1Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, 2Department of Neuropsychiatry, The University of Tokyo Hospital, Bunkyo-ku, Tok...
Guardado en:
Autores principales: | Wada A, Kunii Y, Matsumoto J, Hino M, Nagaoka A, Niwa SI, Yabe H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11adc29c9dbb44079f450890f3f08401 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Old and New Calcineurin Inhibitors in Lupus Nephritis
por: Claudio Ponticelli, et al.
Publicado: (2021) -
FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in <italic toggle="yes">Malassezia</italic>
por: Giuseppe Ianiri, et al.
Publicado: (2017) -
Calcineurin Aα Contributes to IgE-Dependent Mast-Cell Mediator Secretion in Allergic Inflammation
por: Edwin Leong, et al.
Publicado: (2021) -
The Transient Receptor Potential Channel Yvc1 Deletion Recovers the Growth Defect of Calcineurin Mutant Under Endoplasmic Reticulum Stress in Candida albicans
por: Liping Peng, et al.
Publicado: (2021) -
A Review of Calcineurin Biophysics with Implications for Cardiac Physiology
por: Ryan B. Williams, et al.
Publicado: (2021)